Brandon Couillard Analyst Performance

Managing Director, Life Science Tools & Diagnostics Equity Research Analyst at Wells Fargo & Company

Brandon Couillard is a stock analyst at Wells Fargo & Company, covering 23 publicly traded companies across a range of sectors. Over the past year, Brandon Couillard has issued 30 stock ratings, including buy, hold, and sell recommendations. While full access to Brandon Couillard's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Brandon Couillard's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Analyst Rating

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

60 Last 10 Years

Buy Recommendations

59.32% 35 Buy Ratings

Companies Covered

23 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	59.3%	35 ratings
Hold	39.0%	23 ratings
Sell	1.7%	1 ratings

Out of 59 total stock ratings issued by Brandon Couillard at Wells Fargo & Company, the majority (59.3%) have been Buy recommendations, followed by 39.0% Hold and 1.7% Sell.

Best & Worst Calls

• Best Call

  0000.0%

  EXAS

  May 2016

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  EXAS

  May 2015

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	60.9% of companies on NASDAQ	14 companies
NYSE	39.1% of companies on NYSE	9 companies

Brandon Couillard, an analyst at Wells Fargo & Company, currently covers 23 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 21 companies	91.3%
	Computer and Technology 2 companies	8.7%

Brandon Couillard of Wells Fargo & Company specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology companies.

Coverage Industries

Industry	Percentage
MEDICAL SERVICES 5 companies	21.7%
MED INSTRUMENTS 5 companies	21.7%
MED - BIOMED/GENE 4 companies	17.4%
MED PRODUCTS 3 companies	13.0%
MED/DENTAL - SUPP 2 companies	8.7%
INSTRU - SCIENTFC 1 company	4.3%
DENTAL EQUIPMENT & SUPPLIES 1 company	4.3%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC 1 company	4.3%
ELEC MSRNG INST 1 company	4.3%

Brandon Couillard's Ratings History at Wells Fargo & Company

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Time Frame

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
A Agilent Technologies	8/28/2025	Boost Price Target	$122.64	$140.00	Overweight	$0.00 00.00% ROI
CDNA CareDx	8/8/2025	Lower Price Target	$12.01	$14.00	Equal Weight	$0.00 00.00% ROI
MLAB Mesa Laboratories	8/7/2025	Upgrade	$62.01	$67.00	Equal Weight	$0.00 00.00% ROI
WAT Waters	8/5/2025	Lower Price Target	$282.64	$315.00	Equal Weight	$0.00 00.00% ROI
BRKR Bruker	8/5/2025	Lower Price Target	$33.31	$50.00	Overweight	$0.00 00.00% ROI
AVTR Avantor	8/4/2025	Lower Price Target	$11.46	$16.00	Overweight	$0.00 00.00% ROI
BRKR Bruker	8/4/2025	Set Price Target	$34.72	$60.00	Buy	$0.00 00.00% ROI
BIO Bio-Rad Laboratories	8/1/2025	Boost Price Target	$287.26	$265.00	Equal Weight	$0.00 00.00% ROI
RGEN Repligen	7/30/2025	Lower Price Target	$125.03	$175.00	Overweight	$0.00 00.00% ROI
WGS GeneDx	7/30/2025	Boost Price Target	$99.01	$95.00	Equal Weight	$0.00 00.00% ROI
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
TMO Thermo Fisher Scientific	7/24/2025	Lower Price Target	$479.89	$565.00	Overweight	$0.00 00.00% ROI
DHR Danaher	7/23/2025	Lower Price Target	$196.53	$205.00	Equal Weight	$0.00 00.00% ROI
WAT Waters	7/15/2025	Downgrade	$303.93	$330.00	Hold	$0.00 00.00% ROI
BIO Bio-Rad Laboratories	6/9/2025	Lower Price Target	$228.26	$245.00	Equal Weight	$0.00 00.00% ROI
TECH Bio-Techne	5/30/2025	Initiated Coverage	$48.33	$59.00	Overweight	$0.00 00.00% ROI
MLAB Mesa Laboratories	5/30/2025	Lower Price Target	$102.35	$100.00	Underweight	$0.00 00.00% ROI
MYGN Myriad Genetics	5/7/2025	Downgrade	$7.28	$6.00	Equal Weight	$0.00 00.00% ROI
MTD Mettler-Toledo International	5/5/2025	Boost Price Target	$1,103.95	$1,200.00	Equal Weight	$0.00 00.00% ROI
WGS GeneDx	5/1/2025	Lower Price Target	$64.64	$78.00	Equal Weight	$0.00 00.00% ROI
TMO Thermo Fisher Scientific	4/24/2025	Lower Price Target	$432.31	$570.00	Overweight	$0.00 00.00% ROI
A Agilent Technologies	4/21/2025	Lower Price Target	$99.62	$116.00	Hold	$0.00 00.00% ROI
AVTR Avantor	4/17/2025	Lower Price Target	$15.12	$22.00	Overweight	$0.00 00.00% ROI
A Agilent Technologies	4/17/2025	Lower Price Target	$102.59	$135.00	Overweight	$0.00 00.00% ROI
TMO Thermo Fisher Scientific	4/17/2025	Lower Price Target	$432.77	$580.00	Overweight	$0.00 00.00% ROI
RVTY Revvity	4/17/2025	Lower Price Target	$92.75	$102.00	Equal Weight	$0.00 00.00% ROI
MTD Mettler-Toledo International	4/17/2025	Lower Price Target	$1,011.15	$1,125.00	Equal Weight	$0.00 00.00% ROI
BRKR Bruker	4/17/2025	Lower Price Target	$36.46	$60.00	Overweight	$0.00 00.00% ROI
BIO Bio-Rad Laboratories	4/17/2025	Lower Price Target	$239.04	$270.00	Equal Weight	$0.00 00.00% ROI
ALGN Align Technology	1/23/2025	Lower Price Target	$233.07	$260.00	Buy	$0.00 00.00% ROI
HSIC Henry Schein	1/23/2025	Boost Price Target	$74.09	$80.00	Hold	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.